Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hyperaldosteronism

• Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism
• Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism
• Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment
• Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia
• Effect of a Proposed Cav1.3 Inhibitor in Primary Aldosteronism
• The Effect of SAAE on Ventricular Remodeling in PA Patients
• First-in-human Evaluation of [18F]CETO
• Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study
• MR Antagonist and LSD1
• AVS After 1mg DST to Determine Subtype in PA
• A Study of CIN-107 in Adults With Primary Aldosteronism
• Outcomes of AVS With or Without ACTH Stimulation in PA
• Tissue K+ in Primary Hyperaldosteronism
• Calcium Channel Blockade in Primary Aldosteronism
• DP13 - A Phase II Study in Patients With Primary Aldosteronism
• Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA)
• Open-label Study on Treatment of Primary Aldosteronism With Everolimus
• Study of CS-3150 in Patients With Primary Aldosteronism
• Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas
• Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism
• Microvascular Function in Primary Aldosteronism
• Etiology of Sleep Apnea-related Hyperaldosteronism - BP Treatment
• Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Diagnosis of Primary Aldosteronism: Comparison of Post Captopril Active Renin Concentration and Plasma Renin Activity
• The Role of Mineralocorticoid Receptors in Vascular Function
• Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism
• Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?
• The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism
• Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.
• Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary Aldosteronism